600 mg Ceftaroline fosamil

DRUG2 trials

Sponsors

Pfizer

Conditions

Healthy VolunteersRenal Disease

Phase 1

A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects

CompletedNCT01612507

PfizerHealthy Volunteers

Start: 2012-07-31End: 2012-11-30Updated: 2017-09-05

A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects

CompletedNCT01664065

PfizerRenal Disease

Start: 2013-02-28End: 2013-11-30Updated: 2017-09-05

Related Papers

An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis.

2015-10-222 citations

Evaluation of the pharmacokinetics and safety of single and multiple ceftaroline fosamil infusions in healthy Chinese and Western subjects.

2015-08-018 citations